Investigational Drug Information for CA-008
✉ Email this page to a colleague
What is the development status for investigational drug CA-008?
CA-008 is an investigational drug.
There have been 7 clinical trials for CA-008.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 29th 2018.
The most common disease conditions in clinical trials are Pain, Postoperative, Congenital Abnormalities, and Bunion. The leading clinical trial sponsors are Concentric Analgesics and [disabled in preview].
There is one US patent protecting this investigational drug and twenty international patents.
Summary for CA-008
| US Patents | 1 |
| International Patents | 20 |
| US Patent Applications | 7 |
| WIPO Patent Applications | 5 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2018-10-29) |
| Vendors | 9 |
Recent Clinical Trials for CA-008
| Title | Sponsor | Phase |
|---|---|---|
| Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair | Concentric Analgesics | Phase 1/Phase 2 |
| Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 | Concentric Analgesics | Phase 1/Phase 2 |
| Open-Label CA-008 (Vocacapsaicin) in Bunionectomy | Concentric Analgesics | Phase 2 |
